273 related articles for article (PubMed ID: 30716324)
21. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.
Mas L; Lupinacci RM; Cros J; Bachet JB; Coulet F; Svrcek M
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201897
[TBL] [Abstract][Full Text] [Related]
22. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.
Park MA; Zaw T; Yoder SJ; Gomez M; Genilo-Delgado M; Basinski T; Katende E; Dam A; Mok SRS; Monteiro A; Mohammadi A; Jeong DK; Jiang K; Centeno BA; Hodul P; Malafa M; Fleming J; Chen DT; Mo Q; Teer JK; Permuth JB
G3 (Bethesda); 2023 Feb; 13(2):. PubMed ID: 36454217
[TBL] [Abstract][Full Text] [Related]
23. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".
Matthaei H; Wu J; Dal Molin M; Shi C; Perner S; Kristiansen G; Lingohr P; Kalff JC; Wolfgang CL; Kinzler KW; Vogelstein B; Maitra A; Hruban RH
Am J Surg Pathol; 2014 Mar; 38(3):360-3. PubMed ID: 24525507
[TBL] [Abstract][Full Text] [Related]
24. IPMNs with co-occurring invasive cancers: neighbours but not always relatives.
Felsenstein M; Noë M; Masica DL; Hosoda W; Chianchiano P; Fischer CG; Lionheart G; Brosens LAA; Pea A; Yu J; Gemenetzis G; Groot VP; Makary MA; He J; Weiss MJ; Cameron JL; Wolfgang CL; Hruban RH; Roberts NJ; Karchin R; Goggins MG; Wood LD
Gut; 2018 Sep; 67(9):1652-1662. PubMed ID: 29500184
[TBL] [Abstract][Full Text] [Related]
25. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms.
Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J
Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
[TBL] [Abstract][Full Text] [Related]
27. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features.
Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y
Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918
[TBL] [Abstract][Full Text] [Related]
28. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
29. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
[TBL] [Abstract][Full Text] [Related]
30. Diabetes in intraductal papillary mucinous neoplasm of the pancreas and its association with malignancy.
Zhou H; Chen X; Wang C; Lin T; Li X; Cui W; Wang J; Wang Y; Chen X
J Surg Oncol; 2023 Mar; 127(4):625-632. PubMed ID: 36409079
[TBL] [Abstract][Full Text] [Related]
31. Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.
Semaan A; Bernard V; Wong J; Makino Y; Swartzlander DB; Rajapakshe KI; Lee JJ; Officer A; Schmidt CM; Wu HH; Scaife CL; Affolter KE; Nachmanson D; Firpo MA; Yip-Schneider M; Lowy AM; Harismendy O; Sen S; Maitra A; Jakubek YA; Guerrero PA
Cancer Res Commun; 2023 Oct; 3(10):2062-2073. PubMed ID: 37721516
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.
Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N
Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868
[TBL] [Abstract][Full Text] [Related]
33. [A case of incipient pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm, confirmed by multiregion sequencing analysis].
Sato M; Karasaki H; Tominaga M; Sakamoto J; Kimura K; Ohta T; Tanaka S; Mizukami Y
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(4):368-376. PubMed ID: 35400690
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
35. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
36. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Omura N; Vincent A; Li A; Knight S; Yu J; Hruban RH; Goggins M
Clin Cancer Res; 2012 Feb; 18(3):700-12. PubMed ID: 22173550
[TBL] [Abstract][Full Text] [Related]
38. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions.
Kuboki Y; Fischer CG; Beleva Guthrie V; Huang W; Yu J; Chianchiano P; Hosoda W; Zhang H; Zheng L; Shao X; Thompson ED; Waters K; Poling J; He J; Weiss MJ; Wolfgang CL; Goggins MG; Hruban RH; Roberts NJ; Karchin R; Wood LD
J Pathol; 2019 Mar; 247(3):347-356. PubMed ID: 30430578
[TBL] [Abstract][Full Text] [Related]
39. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
40. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
